| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. | Director | Common Stock | 1,958,427 | $26,438,765 | $13.50 | 27 Jan 2025 | Indirect |
| Generation Bio Co. | Director | Stock Option (right to buy) | 30,000 | $275,400 | $4.59 | 04 Jun 2025 | Direct |
| Dyne Therapeutics, Inc. | Director | Stock option (right to buy) | 35,000 | 30 May 2025 | Direct | ||
| Gemini Therapeutics, Inc. /DE | Director, 10%+ Owner | Stock Option (Right to Buy) | 17,245 | 04 Oct 2021 | Direct | ||
| Replimune Group, Inc. | Director | Stock Option (right to buy) | 16,500 | 01 Apr 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GBIO | Generation Bio Co. | 04 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 16:05 |
| DYN | Dyne Therapeutics, Inc. | 30 May 2025 | 1 | $0 | 4 | Director | 03 Jun 2025, 21:39 |
| DYN | Dyne Therapeutics, Inc. | 27 Jan 2025 | 1 | +$14,999,998 | 4 | Director | 29 Jan 2025, 16:15 |
| DYN | Dyne Therapeutics, Inc. | 14 Nov 2024 | 4 | -$25,884 | 4 | Director | 18 Nov 2024, 17:31 |
| GBIO | Generation Bio Co. | 06 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 16:05 |
| DYN | Dyne Therapeutics, Inc. | 22 May 2024 | 1 | $0 | 4 | Director | 24 May 2024, 17:10 |
| DYN | Dyne Therapeutics, Inc. | 01 Mar 2024 | 2 | -$1,398,347 | 4 | Director | 05 Mar 2024, 17:08 |
| DYN | Dyne Therapeutics, Inc. | 26 Feb 2024 | 18 | -$19,626,903 | 4 | Director | 28 Feb 2024, 19:15 |
| DYN | Dyne Therapeutics, Inc. | 21 Feb 2024 | 6 | -$11,339,780 | 4 | Director | 23 Feb 2024, 18:59 |
| DYN | Dyne Therapeutics, Inc. | 15 Feb 2024 | 5 | -$11,867,292 | 4 | Director | 20 Feb 2024, 18:36 |
| GBIO | Generation Bio Co. | 08 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 16:15 |
| DYN | Dyne Therapeutics, Inc. | 24 May 2023 | 1 | $0 | 4 | Director | 25 May 2023, 18:38 |
| DYN | Dyne Therapeutics, Inc. | 12 Dec 2022 | 1 | +$10,000,017 | 4 | Director | 14 Dec 2022, 15:56 |
| GBIO | Generation Bio Co. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 16:05 |
| DYN | Dyne Therapeutics, Inc. | 03 Jun 2022 | 1 | $0 | 4 | Director | 06 Jun 2022, 18:42 |
| REPL | Replimune Group, Inc. | 01 Apr 2022 | 1 | $0 | 4 | Director | 05 Apr 2022, 16:13 |
| IRON | Gemini Therapeutics, Inc. /DE | 04 Oct 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 06 Oct 2021, 16:15 |
| GBIO | Generation Bio Co. | 27 Sep 2021 | 6 | -$2,059,519 | 4 | Director | 29 Sep 2021, 19:16 |
| GBIO | Generation Bio Co. | 22 Sep 2021 | 7 | -$3,511,993 | 4 | Director | 24 Sep 2021, 21:02 |
| GBIO | Generation Bio Co. | 24 Jun 2021 | 4 | -$801,618 | 4 | Director | 28 Jun 2021, 16:57 |
| GBIO | Generation Bio Co. | 21 Jun 2021 | 12 | -$4,635,967 | 4 | Director | 23 Jun 2021, 20:27 |
| GBIO | Generation Bio Co. | 09 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 16:14 |
| DYN | Dyne Therapeutics, Inc. | 26 May 2021 | 1 | $0 | 4 | Director | 27 May 2021, 20:38 |